Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $30.0400 (0.37%) ($29.6000 - $30.5300) on Wed. Jan. 22, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.01% (three month average) | RSI | 55 | Latest Price | $30.0400(0.37%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -1.6% a day on average for past five trading days. | Weekly Trend | EDIT advances 2.3% a week on average for past two weeks. | Market Behavior | Normal for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(63%) ARKG(59%) IWO(58%) XBI(58%) ARKK(55%) | Factors Impacting EDIT price | EDIT will decline at least -1.505% in a week (0% probabilities). VIXM(-32%) VXX(-17%) UUP(-6%) TLT(-3%) IGOV(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.505% (StdDev 3.01%) | Hourly BBV | 0 () | Intraday Trend | 0.4% | | | |
|
Resistance Level | $30.8 | 5 Day Moving Average | $31.08(-3.35%) | 10 Day Moving Average | $31.13(-3.5%) | 20 Day Moving Average | $30.8(-2.47%) | To recent high | -8.4% | To recent low | 48% | Market Cap | $1.866b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |